Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia

Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac

(2017) Thangirala Sudha et al.   International Journal of Nanomedicine

Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac

(2017) Thangirala Sudha et al.   Nanomedicine

Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer

(2017) Dhruba J. Bharali et al.   Nanomedicine-Nanotechnology Biology and Medicine

Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation

(2017) Mathangi Srinivasan et al.   Oncotarget

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts

(2017) Thangirala Sudha et al.   Hormones & Cancer

Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA

(2016) Tong-You Wade Wei et al.   CANCER RESEARCH

Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1

(2016) Noureldien H.E. Darwish et al.   Oncotarget

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

(2016) Mi Park et al.   Cells

The inherent metastasis of leukaemia and its exploitation by sonodynamic therapy

(2015) Matthew Trendowski   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer

(2015) Waseem Hariri et al.   PHARMACEUTICAL RESEARCH

Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target

(2015) Jianbiao Zhou et al.   Oncotarget

Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1

(2015) Sally-Anne Heasman et al.   Oncotarget

The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer

(2014) Mads Hjortso et al.   CURRENT CANCER DRUG TARGETS

LFG-500 Inhibits the Invasion of Cancer Cells via Down-Regulation of PI3K/AKT/NF-κB Signaling Pathway

(2014) Chenglin Li et al.   PLoS One

Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia

(2014) Jianbiao Zhou   World Journal of Stem Cells

Parthenolide: from plant shoots to cancer roots

(2013) Akram Ghantous et al.   DRUG DISCOVERY TODAY

The complexity of NF-κB signaling in inflammation and cancer

(2013) Bastian Hoesel et al.   Molecular Cancer

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

(2013) P. Godwin et al.   Frontiers in Oncology

Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia

(2012) P. Diamanti et al.   BLOOD

Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy

(2012) Jun Ling et al.   CANCER LETTERS

NF-κB as a target for pancreatic cancer therapy

(2012) Carmine Carbone et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target Against Thyroid Cancers

(2012) Xinying Li et al.   THYROID

NF-κB signaling in prostate cancer: A promising therapeutic target?

(2011) Garima Jain et al.   WORLD JOURNAL OF UROLOGY

The NF- B Family of Transcription Factors and Its Regulation

(2009) A. Oeckinghaus et al.   Cold Spring Harbor Perspectives in Biology

HO-1 underlies resistance of AML cells to TNF-induced apoptosis

(2008) S. A. Rushworth et al.   BLOOD

Preclinical targeting of NF-κB and FLT3 pathways in AML cells

(2008) E Griessinger et al.   LEUKEMIA

Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex Karyotype

(2008) Krzysztof Mrózek   SEMINARS IN ONCOLOGY